Published Data Demonstrate Sexual Function Improvement and Preservation with the Minimally Invasive UroLift® System Compared to Medications Prescribed for Benign Prostatic Hyperplasia

byNASDAQ Market NewsJanuary 20, 2021

NASDAQ Market News
Click here to email author

Tiziana Life Sciences to Participate in a Fireside Chat at B. Riley Virtual Oncology Investor Conference on 21 January 2021 at 3 pm ET/8 pm GMT

The overall market was estimated to be $471.7 million in FY2019, and it is expected to grow at a CAGR of 44.03% during the forecast period, 2021-2030

Ads